Elite Pharmaceuticals appoints Kirko Kirkov as Chief Commercial Officer effective Sept. 6, 2022

ELITE PHARMACEUTICALS INC /NV/

Base salary $150k/year; increases to $275k after one year contingent on corporate goals.
Eligible for annual bonus up to 50% of salary (20% personal KPIs, 30% corporate performance).
Upon board approval, granted options to purchase 3,000,000 shares vesting over 3 years.
Kirkov brings 20+ years experience, most recently General Manager at Vertice Pharma.
New position to oversee sales and marketing of commercial products under Elite label.

item 1.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kirko Kirkov

Chief Commercial Officer

ELTP · ELITE PHARMACEUTICALS INC /NV/

Effective: 2022-09-06
Filed: September 7, 2022, 7:59 PM ET

On September 5, 2022, Elite Pharmaceuticals, Inc., a Nevada corporation (the “Registrant”), entered into an employment agreement with Kirko Kirkov to serve as the Registrants’ Chief Commercial Officer effective September 6, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Kirko Kirkov was appointed as Chief Commercial Officer at ELITE PHARMACEUTICALS INC /NV/.

Action: appointed
Role: Chief Commercial Officer

Exact text from the filing

On September 5, 2022, Elite Pharmaceuticals, Inc., a Nevada corporation (the “Registrant”), entered into an employment agreement with Kirko Kirkov to serve as the Registrants’ Chief Commercial Officer effective September 6, 2022.

View on SEC.gov

ELITE PHARMACEUTICALS INC /NV/ filing history →

Source: SEC EDGAR

accession 0001493152-22-025258

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.